#begin document (en_2793.txt); part 000
en_2793.txt	0	0	Buy	VB	(TOP(SQ(VP(VP*	-	-	-	-	*	-
en_2793.txt	0	1	Back	RB	(ADVP*))	-	-	-	-	*	-
en_2793.txt	0	2	or	CC	*	-	-	-	-	*	-
en_2793.txt	0	3	Pay	VB	(VP*	-	-	-	-	*	-
en_2793.txt	0	4	Forward	NNP	(NP*)))	-	-	-	-	*	-
en_2793.txt	0	5	?	.	*))	-	-	-	-	*	-

en_2793.txt	0	0	LONDON	NNP	(TOP(S(NP*	-	-	-	-	*	-
en_2793.txt	0	1	–	NN	*)	-	-	-	-	*	-
en_2793.txt	0	2	When	WRB	(SBAR(WHADVP*)	-	-	-	-	*	-
en_2793.txt	0	3	British	JJ	(S(NP*	-	-	-	-	*	(0
en_2793.txt	0	4	Prime	NNP	*	-	-	-	-	*	-
en_2793.txt	0	5	Minister	NNP	*	-	-	-	-	*	-
en_2793.txt	0	6	David	NNP	*	-	-	-	-	*	-
en_2793.txt	0	7	Cameron	NNP	*)	-	-	-	-	*	0)
en_2793.txt	0	8	asked	VBD	(VP*	-	-	-	-	*	-
en_2793.txt	0	9	me	PRP	(NP*)	-	-	-	-	*	(0)
en_2793.txt	0	10	to	TO	(S(VP*	-	-	-	-	*	-
en_2793.txt	0	11	lead	VB	(VP*	-	-	-	-	*	-
en_2793.txt	0	12	a	DT	(NP(NP*	-	-	-	-	*	-
en_2793.txt	0	13	review	NN	*)	-	-	-	-	*	-
en_2793.txt	0	14	into	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	15	the	DT	(NP(NP*	-	-	-	-	*	-
en_2793.txt	0	16	problem	NN	*)	-	-	-	-	*	-
en_2793.txt	0	17	of	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	18	antimicrobial	JJ	(NP*	-	-	-	-	*	-
en_2793.txt	0	19	resistance	NN	*)))))))))))	-	-	-	-	*	-
en_2793.txt	0	20	,	,	*	-	-	-	-	*	-
en_2793.txt	0	21	the	DT	(NP(NP*	-	-	-	-	*	-
en_2793.txt	0	22	last	JJ	*	-	-	-	-	*	-
en_2793.txt	0	23	thing	NN	*)	-	-	-	-	*	-
en_2793.txt	0	24	I	PRP	(SBAR(S(NP*)	-	-	-	-	*	(0)
en_2793.txt	0	25	expected	VBD	(VP*))))	-	-	-	-	*	-
en_2793.txt	0	26	was	VBD	(VP*	-	-	-	-	*	-
en_2793.txt	0	27	that	IN	(SBAR*	-	-	-	-	*	-
en_2793.txt	0	28	accepting	VBG	(S(S(VP*	-	-	-	-	*	-
en_2793.txt	0	29	the	DT	(NP*	-	-	-	-	*	-
en_2793.txt	0	30	position	NN	*)))	-	-	-	-	*	-
en_2793.txt	0	31	would	MD	(VP*	-	-	-	-	*	-
en_2793.txt	0	32	lead	VB	(VP*	-	-	-	-	*	-
en_2793.txt	0	33	me	PRP	(S(NP*)	-	-	-	-	*	(0)
en_2793.txt	0	34	to	TO	(VP*	-	-	-	-	*	-
en_2793.txt	0	35	question	VB	(VP*	-	-	-	-	*	-
en_2793.txt	0	36	one	CD	(NP(NP(NP*)	-	-	-	-	*	-
en_2793.txt	0	37	of	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	38	the	DT	(NP(NP*	-	-	-	-	*	-
en_2793.txt	0	39	most	RBS	(ADJP*	-	-	-	-	*	-
en_2793.txt	0	40	popular	JJ	*)	-	-	-	-	*	-
en_2793.txt	0	41	tools	NNS	*)	-	-	-	-	*	-
en_2793.txt	0	42	for	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	43	corporate	JJ	(NP*	-	-	-	-	*	-
en_2793.txt	0	44	financial	JJ	*	-	-	-	-	*	-
en_2793.txt	0	45	management	NN	*)))))	-	-	-	-	*	-
en_2793.txt	0	46	:	:	*	-	-	-	-	*	-
en_2793.txt	0	47	share	NN	(NP*	-	-	-	-	*	-
en_2793.txt	0	48	buybacks	NNS	*))))))))))	-	-	-	-	*	-
en_2793.txt	0	49	.	.	*))	-	-	-	-	*	-

en_2793.txt	0	0	The	DT	(TOP(S(NP(NP*	-	-	-	-	*	(1
en_2793.txt	0	1	problem	NN	*)	-	-	-	-	*	-
en_2793.txt	0	2	of	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	3	antimicrobial	JJ	(NP*	-	-	-	-	*	-
en_2793.txt	0	4	resistance	NN	*)))	-	-	-	-	*	1)
en_2793.txt	0	5	is	VBZ	(VP*	-	-	-	-	*	-
en_2793.txt	0	6	a	DT	(NP*	-	-	-	-	*	-
en_2793.txt	0	7	serious	JJ	*	-	-	-	-	*	-
en_2793.txt	0	8	one	CD	*))	-	-	-	-	*	-
en_2793.txt	0	9	.	.	*))	-	-	-	-	*	-

en_2793.txt	0	0	Left	VBN	(TOP(S(S(VP*	-	-	-	-	*	-
en_2793.txt	0	1	unaddressed	JJ	(S(ADJP*))))	-	-	-	-	*	-
en_2793.txt	0	2	,	,	*	-	-	-	-	*	-
en_2793.txt	0	3	it	PRP	(NP*)	-	-	-	-	*	(1)
en_2793.txt	0	4	could	MD	(VP*	-	-	-	-	*	-
en_2793.txt	0	5	be	VB	(VP*	-	-	-	-	*	-
en_2793.txt	0	6	responsible	JJ	(ADJP(ADJP*	-	-	-	-	*	-
en_2793.txt	0	7	by	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	8	2050	CD	(NP*)))	-	-	-	-	*	-
en_2793.txt	0	9	for	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	10	the	DT	(NP*	-	-	-	-	*	-
en_2793.txt	0	11	deaths	NNS	*))	-	-	-	-	*	-
en_2793.txt	0	12	of	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	13	some	DT	(NP(NP(NP(QP*	-	-	-	-	*	-
en_2793.txt	0	14	ten	CD	*	-	-	-	-	*	-
en_2793.txt	0	15	million	CD	*)	-	-	-	-	*	-
en_2793.txt	0	16	people	NNS	*)	-	-	-	-	*	-
en_2793.txt	0	17	a	DT	(NP*	-	-	-	-	*	-
en_2793.txt	0	18	year	NN	*))	-	-	-	-	*	-
en_2793.txt	0	19	,	,	*	-	-	-	-	*	-
en_2793.txt	0	20	more	RBR	(ADVP(ADVP*)	-	-	-	-	*	-
en_2793.txt	0	21	than	IN	(SBAR*	-	-	-	-	*	-
en_2793.txt	0	22	currently	RB	(S(ADVP*)	-	-	-	-	*	-
en_2793.txt	0	23	die	VBP	(VP*	-	-	-	-	*	-
en_2793.txt	0	24	of	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	25	cancer	NN	(NP(NP*)	-	-	-	-	*	-
en_2793.txt	0	26	,	,	*	-	-	-	-	*	-
en_2793.txt	0	27	along	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	28	with	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	29	an	DT	(NP(NP*	-	-	-	-	*	-
en_2793.txt	0	30	astonishing	JJ	*	-	-	-	-	*	-
en_2793.txt	0	31	$	$	(QP*	-	-	-	-	*	-
en_2793.txt	0	32	100	CD	*	-	-	-	-	*	-
en_2793.txt	0	33	trillion	CD	*))	-	-	-	-	*	-
en_2793.txt	0	34	in	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	35	economic	JJ	(NP*	-	-	-	-	*	-
en_2793.txt	0	36	damage	NN	*))))))))))))))))	-	-	-	-	*	-
en_2793.txt	0	37	.	.	*))	-	-	-	-	*	-

en_2793.txt	0	0	Fortunately	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_2793.txt	0	1	,	,	*	-	-	-	-	*	-
en_2793.txt	0	2	however	RB	(ADVP*)	-	-	-	-	*	-
en_2793.txt	0	3	,	,	*	-	-	-	-	*	-
en_2793.txt	0	4	there	EX	(NP*)	-	-	-	-	*	-
en_2793.txt	0	5	is	VBZ	(VP*	-	-	-	-	*	-
en_2793.txt	0	6	much	JJ	(ADJP*	-	-	-	-	*	-
en_2793.txt	0	7	we	PRP	(SBAR(S(NP*)	-	-	-	-	*	-
en_2793.txt	0	8	can	MD	(VP*	-	-	-	-	*	-
en_2793.txt	0	9	do	VB	(VP*	-	-	-	-	*	-
en_2793.txt	0	10	to	TO	(S(VP*	-	-	-	-	*	-
en_2793.txt	0	11	mitigate	VB	(VP*	-	-	-	-	*	-
en_2793.txt	0	12	the	DT	(NP*	-	-	-	-	*	-
en_2793.txt	0	13	threat	NN	*)	-	-	-	-	*	-
en_2793.txt	0	14	–	SYM	(X*))))	-	-	-	-	*	-
en_2793.txt	0	15	provided	VBN	(PP*	-	-	-	-	*	-
en_2793.txt	0	16	that	IN	(SBAR*	-	-	-	-	*	-
en_2793.txt	0	17	adequate	JJ	(S(NP*	-	-	-	-	*	-
en_2793.txt	0	18	resources	NNS	*)	-	-	-	-	*	-
en_2793.txt	0	19	are	VBP	(VP*	-	-	-	-	*	-
en_2793.txt	0	20	made	VBN	(VP*	-	-	-	-	*	-
en_2793.txt	0	21	available	JJ	(S(ADJP*)))))))))))))	-	-	-	-	*	-
en_2793.txt	0	22	.	.	*))	-	-	-	-	*	-

en_2793.txt	0	0	One	CD	(TOP(S(NP(NP*	-	-	-	-	*	-
en_2793.txt	0	1	important	JJ	*	-	-	-	-	*	-
en_2793.txt	0	2	avenue	NN	*)	-	-	-	-	*	-
en_2793.txt	0	3	to	TO	(SBAR(S(VP*	-	-	-	-	*	-
en_2793.txt	0	4	pursue	VB	(VP*)))))	-	-	-	-	*	-
en_2793.txt	0	5	is	VBZ	(VP*	-	-	-	-	*	-
en_2793.txt	0	6	the	DT	(NP(NP*	-	-	-	-	*	-
en_2793.txt	0	7	development	NN	*)	-	-	-	-	*	-
en_2793.txt	0	8	of	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	9	new	JJ	(NP*	-	-	-	-	*	-
en_2793.txt	0	10	drugs	NNS	*))))	-	-	-	-	*	-
en_2793.txt	0	11	.	.	*))	-	-	-	-	*	-

en_2793.txt	0	0	In	IN	(TOP(S(PP*	-	-	-	-	*	-
en_2793.txt	0	1	a	DT	(NP*	-	-	-	-	*	-
en_2793.txt	0	2	forthcoming	JJ	*	-	-	-	-	*	-
en_2793.txt	0	3	paper	NN	*))	-	-	-	-	*	-
en_2793.txt	0	4	,	,	*	-	-	-	-	*	-
en_2793.txt	0	5	the	DT	(NP(NP*	-	-	-	-	*	(2
en_2793.txt	0	6	Review	NNP	*)	-	-	-	-	*	-
en_2793.txt	0	7	on	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	8	Antimicrobial	NNP	(NP*	-	-	-	-	*	-
en_2793.txt	0	9	Resistance	NN	*)))	-	-	-	-	*	2)
en_2793.txt	0	10	estimates	VBZ	(VP*	-	-	-	-	*	-
en_2793.txt	0	11	that	IN	(SBAR*	-	-	-	-	*	-
en_2793.txt	0	12	bringing	VBG	(S(S(VP(VP*	-	-	-	-	*	-
en_2793.txt	0	13	new	JJ	(NP*	-	-	-	-	*	-
en_2793.txt	0	14	antimicrobials	NNS	*)	-	-	-	-	*	-
en_2793.txt	0	15	to	TO	(PP*	-	-	-	-	*	-
en_2793.txt	0	16	market	NN	(NP*)))	-	-	-	-	*	-
en_2793.txt	0	17	and	CC	*	-	-	-	-	*	-
en_2793.txt	0	18	improving	VBG	(VP*	-	-	-	-	*	-
en_2793.txt	0	19	their	PRP$	(NP*	-	-	-	-	*	(2)
en_2793.txt	0	20	administration	NN	*))))	-	-	-	-	*	-
en_2793.txt	0	21	will	MD	(VP*	-	-	-	-	*	-
en_2793.txt	0	22	cost	VB	(VP*	-	-	-	-	*	-
en_2793.txt	0	23	about	IN	(NP(NP(QP*	-	-	-	-	*	-
en_2793.txt	0	24	$	$	*	-	-	-	-	*	-
en_2793.txt	0	25	25	CD	*	-	-	-	-	*	-
en_2793.txt	0	26	billion	CD	*))	-	-	-	-	*	-
en_2793.txt	0	27	–	SYM	(X(X*)	-	-	-	-	*	-
en_2793.txt	0	28	a	DT	(NP(NP*	-	-	-	-	*	-
en_2793.txt	0	29	significant	JJ	*	-	-	-	-	*	-
en_2793.txt	0	30	sum	NN	*)	-	-	-	-	*	-
en_2793.txt	0	31	,	,	*	-	-	-	-	*	-
en_2793.txt	0	32	but	CC	*	-	-	-	-	*	-
en_2793.txt	0	33	one	CD	(NP(NP*)	-	-	-	-	*	-
en_2793.txt	0	34	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_2793.txt	0	35	pales	VBZ	(S(VP*	-	-	-	-	*	-
en_2793.txt	0	36	in	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	37	comparison	NN	(NP(NP*)	-	-	-	-	*	-
en_2793.txt	0	38	to	TO	(PP*	-	-	-	-	*	-
en_2793.txt	0	39	the	DT	(NP(NP*	-	-	-	-	*	-
en_2793.txt	0	40	costs	NNS	*)	-	-	-	-	*	-
en_2793.txt	0	41	to	TO	(PP*	-	-	-	-	*	-
en_2793.txt	0	42	society	NN	(NP*)))))))))))))	-	-	-	-	*	-
en_2793.txt	0	43	if	IN	(SBAR*	-	-	-	-	*	-
en_2793.txt	0	44	the	DT	(S(NP*	-	-	-	-	*	(3
en_2793.txt	0	45	problem	NN	*)	-	-	-	-	*	3)
en_2793.txt	0	46	is	VBZ	(VP*	-	-	-	-	*	-
en_2793.txt	0	47	not	RB	*	-	-	-	-	*	-
en_2793.txt	0	48	checked	VBN	(VP*)))))))))	-	-	-	-	*	-
en_2793.txt	0	49	.	.	*))	-	-	-	-	*	-

en_2793.txt	0	0	It	PRP	(TOP(S(NP*)	-	-	-	-	*	(3)
en_2793.txt	0	1	is	VBZ	(VP*	-	-	-	-	*	-
en_2793.txt	0	2	also	RB	(ADVP*)	-	-	-	-	*	-
en_2793.txt	0	3	roughly	RB	*	-	-	-	-	*	-
en_2793.txt	0	4	what	WP	(SBAR(WHNP*)	-	-	-	-	*	-
en_2793.txt	0	5	two	CD	(S(NP(NP*)	-	-	-	-	*	-
en_2793.txt	0	6	of	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	7	the	DT	(NP(NP*	-	-	-	-	*	(4
en_2793.txt	0	8	world	NN	*	-	-	-	-	*	-
en_2793.txt	0	9	'	POS	*)	-	-	-	-	*	-
en_2793.txt	0	10	s	JJ	*	-	-	-	-	*	-
en_2793.txt	0	11	largest	JJS	*	-	-	-	-	*	-
en_2793.txt	0	12	pharmaceutical	JJ	*	-	-	-	-	*	-
en_2793.txt	0	13	companies	NNS	*)))	-	-	-	-	*	4)
en_2793.txt	0	14	will	MD	(VP*	-	-	-	-	*	-
en_2793.txt	0	15	spend	VB	(VP*	-	-	-	-	*	-
en_2793.txt	0	16	this	DT	(NP*	-	-	-	-	*	-
en_2793.txt	0	17	year	NN	*)	-	-	-	-	*	-
en_2793.txt	0	18	buying	VBG	(S(VP*	-	-	-	-	*	-
en_2793.txt	0	19	back	RP	(PRT*)	-	-	-	-	*	-
en_2793.txt	0	20	their	PRP$	(NP*	-	-	-	-	*	(4)
en_2793.txt	0	21	own	JJ	*	-	-	-	-	*	-
en_2793.txt	0	22	shares	NNS	*))))))))	-	-	-	-	*	-
en_2793.txt	0	23	.	.	*))	-	-	-	-	*	-

en_2793.txt	0	0	While	IN	(TOP(S(SBAR*	-	-	-	-	*	-
en_2793.txt	0	1	the	DT	(S(NP*	-	-	-	-	*	(2
en_2793.txt	0	2	review	NN	*)	-	-	-	-	*	2)
en_2793.txt	0	3	has	VBZ	(VP*	-	-	-	-	*	-
en_2793.txt	0	4	yet	RB	(ADVP*)	-	-	-	-	*	-
en_2793.txt	0	5	to	TO	(S(VP*	-	-	-	-	*	-
en_2793.txt	0	6	come	VB	(VP*	-	-	-	-	*	-
en_2793.txt	0	7	up	RP	(PRT*)	-	-	-	-	*	-
en_2793.txt	0	8	with	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	9	recommendations	NNS	(NP(NP*)	-	-	-	-	*	-
en_2793.txt	0	10	for	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	11	financing	VBG	(S(VP*	-	-	-	-	*	-
en_2793.txt	0	12	the	DT	(NP(NP*	-	-	-	-	*	-
en_2793.txt	0	13	development	NN	*)	-	-	-	-	*	-
en_2793.txt	0	14	of	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	15	new	JJ	(NP*	-	-	-	-	*	-
en_2793.txt	0	16	drugs	NNS	*))))))))))))))	-	-	-	-	*	-
en_2793.txt	0	17	,	,	*	-	-	-	-	*	-
en_2793.txt	0	18	it	PRP	(NP*)	-	-	-	-	*	-
en_2793.txt	0	19	seems	VBZ	(VP*	-	-	-	-	*	-
en_2793.txt	0	20	clear	JJ	(ADJP*	-	-	-	-	*	-
en_2793.txt	0	21	to	TO	(PP*	-	-	-	-	*	-
en_2793.txt	0	22	me	PRP	(NP*)))	-	-	-	-	*	(0)
en_2793.txt	0	23	that	IN	(SBAR*	-	-	-	-	*	-
en_2793.txt	0	24	it	PRP	(S(NP*)	-	-	-	-	*	(2)
en_2793.txt	0	25	is	VBZ	(VP*	-	-	-	-	*	-
en_2793.txt	0	26	well	RB	(PP(ADVP*)	-	-	-	-	*	-
en_2793.txt	0	27	within	IN	*	-	-	-	-	*	-
en_2793.txt	0	28	the	DT	(NP(NP*	-	-	-	-	*	-
en_2793.txt	0	29	capacity	NN	*)	-	-	-	-	*	-
en_2793.txt	0	30	of	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	31	the	DT	(NP*	-	-	-	-	*	(5
en_2793.txt	0	32	pharmaceutical	JJ	*	-	-	-	-	*	-
en_2793.txt	0	33	industry	NN	*))))	-	-	-	-	*	5)
en_2793.txt	0	34	to	TO	(S(VP*	-	-	-	-	*	-
en_2793.txt	0	35	contribute	VB	(VP*)))))))	-	-	-	-	*	-
en_2793.txt	0	36	.	.	*))	-	-	-	-	*	-

en_2793.txt	0	0	A	DT	(TOP(S(NP(NP*	-	-	-	-	*	(6
en_2793.txt	0	1	common	JJ	*	-	-	-	-	*	-
en_2793.txt	0	2	argument	NN	*)	-	-	-	-	*	-
en_2793.txt	0	3	made	VBN	(VP*	-	-	-	-	*	-
en_2793.txt	0	4	by	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	5	drug	NN	(NP*	-	-	-	-	*	(7
en_2793.txt	0	6	companies	NNS	*))))	-	-	-	-	*	6)|7)
en_2793.txt	0	7	is	VBZ	(VP*	-	-	-	-	*	-
en_2793.txt	0	8	that	IN	(SBAR*	-	-	-	-	*	-
en_2793.txt	0	9	they	PRP	(S(NP*)	-	-	-	-	*	(7)
en_2793.txt	0	10	need	VBP	(VP*	-	-	-	-	*	-
en_2793.txt	0	11	to	TO	(S(VP*	-	-	-	-	*	-
en_2793.txt	0	12	be	VB	(VP*	-	-	-	-	*	-
en_2793.txt	0	13	guaranteed	VBN	(VP*	-	-	-	-	*	-
en_2793.txt	0	14	a	DT	(NP*	-	-	-	-	*	-
en_2793.txt	0	15	reward	NN	*)	-	-	-	-	*	-
en_2793.txt	0	16	if	IN	(SBAR*	-	-	-	-	*	-
en_2793.txt	0	17	they	PRP	(S(NP*)	-	-	-	-	*	(7)
en_2793.txt	0	18	are	VBP	(VP*	-	-	-	-	*	-
en_2793.txt	0	19	to	TO	(S(VP*	-	-	-	-	*	-
en_2793.txt	0	20	invest	VB	(VP*	-	-	-	-	*	-
en_2793.txt	0	21	in	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	22	developing	VBG	(S(VP*	-	-	-	-	*	-
en_2793.txt	0	23	medicines	NNS	(NP(NP*)	-	-	-	-	*	-
en_2793.txt	0	24	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_2793.txt	0	25	are	VBP	(S(VP*	-	-	-	-	*	-
en_2793.txt	0	26	unlikely	JJ	(ADJP*	-	-	-	-	*	-
en_2793.txt	0	27	to	TO	(S(VP*	-	-	-	-	*	-
en_2793.txt	0	28	deliver	VB	(VP*	-	-	-	-	*	-
en_2793.txt	0	29	the	DT	(NP(NP*	-	-	-	-	*	-
en_2793.txt	0	30	kind	NN	*)	-	-	-	-	*	-
en_2793.txt	0	31	of	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	32	returns	NNS	(NP(NP*)	-	-	-	-	*	-
en_2793.txt	0	33	that	IN	(SBAR*	-	-	-	-	*	-
en_2793.txt	0	34	other	JJ	(S(NP*	-	-	-	-	*	-
en_2793.txt	0	35	investments	NNS	*)	-	-	-	-	*	-
en_2793.txt	0	36	may	MD	(VP*	-	-	-	-	*	-
en_2793.txt	0	37	provide	VB	(VP*))))))))))))))))))))))))))))))))	-	-	-	-	*	-
en_2793.txt	0	38	.	.	*))	-	-	-	-	*	-

en_2793.txt	0	0	The	DT	(TOP(S(NP(NP*	-	-	-	-	*	-
en_2793.txt	0	1	only	JJ	*	-	-	-	-	*	-
en_2793.txt	0	2	sure	JJ	*	-	-	-	-	*	-
en_2793.txt	0	3	way	NN	*)	-	-	-	-	*	-
en_2793.txt	0	4	to	TO	(SBAR(S(VP*	-	-	-	-	*	-
en_2793.txt	0	5	guarantee	VB	(VP*	-	-	-	-	*	-
en_2793.txt	0	6	drug	NN	(NP*	-	-	-	-	*	-
en_2793.txt	0	7	development	NN	*))))))	-	-	-	-	*	-
en_2793.txt	0	8	,	,	(PRN*	-	-	-	-	*	-
en_2793.txt	0	9	the	DT	(S(NP*	-	-	-	-	*	(6
en_2793.txt	0	10	argument	NN	*)	-	-	-	-	*	6)
en_2793.txt	0	11	goes	VBZ	(VP*))	-	-	-	-	*	-
en_2793.txt	0	12	,	,	*)	-	-	-	-	*	-
en_2793.txt	0	13	is	VBZ	(VP*	-	-	-	-	*	-
en_2793.txt	0	14	to	TO	(S(VP*	-	-	-	-	*	-
en_2793.txt	0	15	allow	VB	(VP*	-	-	-	-	*	-
en_2793.txt	0	16	prices	NNS	(S(NP*)	-	-	-	-	*	-
en_2793.txt	0	17	to	TO	(VP*	-	-	-	-	*	-
en_2793.txt	0	18	rise	VB	(VP*	-	-	-	-	*	-
en_2793.txt	0	19	until	IN	(SBAR*	-	-	-	-	*	-
en_2793.txt	0	20	demand	NN	(S(NP*)	-	-	-	-	*	-
en_2793.txt	0	21	matches	VBZ	(VP*	-	-	-	-	*	-
en_2793.txt	0	22	supply	NN	(NP*)))))))))))	-	-	-	-	*	-
en_2793.txt	0	23	.	.	*))	-	-	-	-	*	-

en_2793.txt	0	0	And	CC	(TOP(S*	-	-	-	-	*	-
en_2793.txt	0	1	yet	RB	(ADVP*)	-	-	-	-	*	-
en_2793.txt	0	2	there	EX	(NP*)	-	-	-	-	*	-
en_2793.txt	0	3	is	VBZ	(VP*	-	-	-	-	*	-
en_2793.txt	0	4	a	DT	(NP(NP*	-	-	-	-	*	-
en_2793.txt	0	5	good	JJ	*	-	-	-	-	*	-
en_2793.txt	0	6	reason	NN	*)	-	-	-	-	*	-
en_2793.txt	0	7	why	WRB	(SBAR(WHADVP*)	-	-	-	-	*	-
en_2793.txt	0	8	the	DT	(S(NP*	-	-	-	-	*	(5
en_2793.txt	0	9	pharmaceutical	JJ	*	-	-	-	-	*	-
en_2793.txt	0	10	industry	NN	*)	-	-	-	-	*	5)
en_2793.txt	0	11	can	MD	(VP*	-	-	-	-	*	-
en_2793.txt	0	12	and	CC	*	-	-	-	-	*	-
en_2793.txt	0	13	should	MD	*	-	-	-	-	*	-
en_2793.txt	0	14	play	VB	(VP*	-	-	-	-	*	-
en_2793.txt	0	15	a	DT	(NP*	-	-	-	-	*	-
en_2793.txt	0	16	major	JJ	*	-	-	-	-	*	-
en_2793.txt	0	17	role	NN	*)	-	-	-	-	*	-
en_2793.txt	0	18	in	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	19	financing	VBG	(S(VP*	-	-	-	-	*	-
en_2793.txt	0	20	something	NN	(NP*)	-	-	-	-	*	-
en_2793.txt	0	21	like	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	22	a	DT	(NP*	-	-	-	-	*	-
en_2793.txt	0	23	common	JJ	*	-	-	-	-	*	-
en_2793.txt	0	24	``	``	*	-	-	-	-	*	-
en_2793.txt	0	25	Innovation	NNP	*	-	-	-	-	*	-
en_2793.txt	0	26	Fund	NNP	*))	-	-	-	-	*	-
en_2793.txt	0	27	''	''	*	-	-	-	-	*	-
en_2793.txt	0	28	to	TO	(S(VP*	-	-	-	-	*	-
en_2793.txt	0	29	provide	VB	(VP*	-	-	-	-	*	-
en_2793.txt	0	30	financing	NN	(NP(NP*)	-	-	-	-	*	-
en_2793.txt	0	31	for	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	32	early-stage	JJ	(NP*	-	-	-	-	*	-
en_2793.txt	0	33	research	NN	*)))	-	-	-	-	*	-
en_2793.txt	0	34	into	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	35	solving	VBG	(S(VP*	-	-	-	-	*	-
en_2793.txt	0	36	the	DT	(NP(NP*	-	-	-	-	*	-
en_2793.txt	0	37	problem	NN	*)	-	-	-	-	*	-
en_2793.txt	0	38	of	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	39	antimicrobial	JJ	(NP*	-	-	-	-	*	-
en_2793.txt	0	40	resistance	NN	*))))))))))))))))))	-	-	-	-	*	-
en_2793.txt	0	41	.	.	*))	-	-	-	-	*	-

en_2793.txt	0	0	And	CC	(TOP(S*	-	-	-	-	*	-
en_2793.txt	0	1	that	DT	(NP*	-	-	-	-	*	-
en_2793.txt	0	2	reason	NN	*)	-	-	-	-	*	-
en_2793.txt	0	3	is	VBZ	(VP*	-	-	-	-	*	-
en_2793.txt	0	4	one	CD	(NP(NP(NP*)	-	-	-	-	*	-
en_2793.txt	0	5	that	IN	(SBAR(WHNP*)	-	-	-	-	*	-
en_2793.txt	0	6	I	PRP	(S(NP*)	-	-	-	-	*	(0)
en_2793.txt	0	7	became	VBD	(VP*	-	-	-	-	*	-
en_2793.txt	0	8	familiar	JJ	(ADJP*	-	-	-	-	*	-
en_2793.txt	0	9	with	IN	(PP*))	-	-	-	-	*	-
en_2793.txt	0	10	during	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	11	my	PRP$	(NP(NP*	-	-	-	-	*	(0)
en_2793.txt	0	12	years	NNS	*)	-	-	-	-	*	-
en_2793.txt	0	13	at	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	14	Goldman	NNP	(NP*	-	-	-	-	*	-
en_2793.txt	0	15	Sachs	NNP	*))))))))	-	-	-	-	*	-
en_2793.txt	0	16	:	:	*	-	-	-	-	*	-
en_2793.txt	0	17	enlightened	VBN	(NP*	-	-	-	-	*	-
en_2793.txt	0	18	self-interest	NN	*)))	-	-	-	-	*	-
en_2793.txt	0	19	.	.	*))	-	-	-	-	*	-

en_2793.txt	0	0	Six	CD	(TOP(S(PP(NP*	-	-	-	-	*	-
en_2793.txt	0	1	years	NNS	*)	-	-	-	-	*	-
en_2793.txt	0	2	after	IN	*	-	-	-	-	*	-
en_2793.txt	0	3	the	DT	(NP(NP*	-	-	-	-	*	-
en_2793.txt	0	4	eruption	NN	*)	-	-	-	-	*	-
en_2793.txt	0	5	of	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	6	the	DT	(NP*	-	-	-	-	*	-
en_2793.txt	0	7	global	JJ	*	-	-	-	-	*	-
en_2793.txt	0	8	financial	JJ	*	-	-	-	-	*	-
en_2793.txt	0	9	crisis	NN	*))))	-	-	-	-	*	-
en_2793.txt	0	10	,	,	*	-	-	-	-	*	-
en_2793.txt	0	11	the	DT	(NP*	-	-	-	-	*	(5
en_2793.txt	0	12	banking	NN	*	-	-	-	-	*	-
en_2793.txt	0	13	industry	NN	*)	-	-	-	-	*	5)
en_2793.txt	0	14	is	VBZ	(VP*	-	-	-	-	*	-
en_2793.txt	0	15	still	RB	(ADVP*)	-	-	-	-	*	-
en_2793.txt	0	16	widely	RB	(ADVP*)	-	-	-	-	*	-
en_2793.txt	0	17	blamed	VBN	(VP*	-	-	-	-	*	-
en_2793.txt	0	18	for	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	19	the	DT	(NP*	-	-	-	-	*	-
en_2793.txt	0	20	catastrophe	NN	*))))	-	-	-	-	*	-
en_2793.txt	0	21	.	.	*))	-	-	-	-	*	-

en_2793.txt	0	0	And	CC	(TOP(S*	-	-	-	-	*	-
en_2793.txt	0	1	,	,	*	-	-	-	-	*	-
en_2793.txt	0	2	as	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	3	a	DT	(NP*	-	-	-	-	*	-
en_2793.txt	0	4	result	NN	*))	-	-	-	-	*	-
en_2793.txt	0	5	,	,	*	-	-	-	-	*	-
en_2793.txt	0	6	banks	NNS	(NP*)	-	-	-	-	*	(8)
en_2793.txt	0	7	are	VBP	(VP*	-	-	-	-	*	-
en_2793.txt	0	8	being	VBG	(VP*	-	-	-	-	*	-
en_2793.txt	0	9	hit	VBN	(VP*	-	-	-	-	*	-
en_2793.txt	0	10	with	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	11	regulatory	JJ	(NP(NP*	-	-	-	-	*	-
en_2793.txt	0	12	constraints	NNS	*)	-	-	-	-	*	-
en_2793.txt	0	13	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_2793.txt	0	14	limit	VBP	(S(VP*	-	-	-	-	*	-
en_2793.txt	0	15	some	DT	(NP(NP*	-	-	-	-	*	-
en_2793.txt	0	16	aspects	NNS	*)	-	-	-	-	*	-
en_2793.txt	0	17	of	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	18	their	PRP$	(NP*	-	-	-	-	*	(8)
en_2793.txt	0	19	business	NN	*)))))))))))	-	-	-	-	*	-
en_2793.txt	0	20	.	.	*))	-	-	-	-	*	-

en_2793.txt	0	0	I	PRP	(TOP(S(NP*)	-	-	-	-	*	(0)
en_2793.txt	0	1	suspect	VBP	(VP*	-	-	-	-	*	-
en_2793.txt	0	2	that	IN	(SBAR*	-	-	-	-	*	-
en_2793.txt	0	3	if	IN	(S(SBAR*	-	-	-	-	*	-
en_2793.txt	0	4	the	DT	(S(NP*	-	-	-	-	*	(5
en_2793.txt	0	5	industry	NN	*)	-	-	-	-	*	5)
en_2793.txt	0	6	had	VBD	(VP*	-	-	-	-	*	-
en_2793.txt	0	7	shown	VBN	(VP*	-	-	-	-	*	-
en_2793.txt	0	8	greater	JJR	(NP(NP*	-	-	-	-	*	-
en_2793.txt	0	9	leadership	NN	*)	-	-	-	-	*	-
en_2793.txt	0	10	on	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	11	issues	NNS	(NP(NP*)	-	-	-	-	*	-
en_2793.txt	0	12	–	SYM	(PP(X*)	-	-	-	-	*	-
en_2793.txt	0	13	for	IN	*	-	-	-	-	*	-
en_2793.txt	0	14	example	NN	(NP*)))))))))	-	-	-	-	*	-
en_2793.txt	0	15	,	,	*	-	-	-	-	*	-
en_2793.txt	0	16	excessive	JJ	(NP*	-	-	-	-	*	-
en_2793.txt	0	17	executive	JJ	*	-	-	-	-	*	-
en_2793.txt	0	18	pay	NN	*)	-	-	-	-	*	-
en_2793.txt	0	19	–	SYM	(X*)	-	-	-	-	*	-
en_2793.txt	0	20	they	PRP	(NP*)	-	-	-	-	*	(5)
en_2793.txt	0	21	would	MD	(VP*	-	-	-	-	*	-
en_2793.txt	0	22	have	VB	(VP*	-	-	-	-	*	-
en_2793.txt	0	23	found	VBN	(VP*	-	-	-	-	*	-
en_2793.txt	0	24	themselves	PRP	(NP*)	-	-	-	-	*	(5)
en_2793.txt	0	25	in	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	26	a	DT	(NP(NP*	-	-	-	-	*	-
en_2793.txt	0	27	much	RB	(ADJP(ADVP*	-	-	-	-	*	-
en_2793.txt	0	28	more	RBR	*)	-	-	-	-	*	-
en_2793.txt	0	29	favorable	JJ	*)	-	-	-	-	*	-
en_2793.txt	0	30	environment	NN	*)	-	-	-	-	*	-
en_2793.txt	0	31	today	NN	(NP*)))))))))	-	-	-	-	*	-
en_2793.txt	0	32	.	.	*))	-	-	-	-	*	-

en_2793.txt	0	0	The	DT	(TOP(S(NP*	-	-	-	-	*	-
en_2793.txt	0	1	same	JJ	*)	-	-	-	-	*	-
en_2793.txt	0	2	is	VBZ	(VP*	-	-	-	-	*	-
en_2793.txt	0	3	true	JJ	(ADJP*	-	-	-	-	*	-
en_2793.txt	0	4	of	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	5	the	DT	(NP*	-	-	-	-	*	(5
en_2793.txt	0	6	pharmaceutical	JJ	*	-	-	-	-	*	-
en_2793.txt	0	7	industry	NN	*))))	-	-	-	-	*	5)
en_2793.txt	0	8	.	.	*))	-	-	-	-	*	-

en_2793.txt	0	0	Share	NN	(TOP(S(S(NP*	-	-	-	-	*	-
en_2793.txt	0	1	buybacks	NNS	*)	-	-	-	-	*	-
en_2793.txt	0	2	can	MD	(VP*	-	-	-	-	*	-
en_2793.txt	0	3	sometimes	RB	(ADVP*)	-	-	-	-	*	-
en_2793.txt	0	4	be	VB	(VP*	-	-	-	-	*	-
en_2793.txt	0	5	legitimate	JJ	(ADJP*))))	-	-	-	-	*	-
en_2793.txt	0	6	,	,	*	-	-	-	-	*	-
en_2793.txt	0	7	but	CC	*	-	-	-	-	*	-
en_2793.txt	0	8	on	IN	(S(PP*	-	-	-	-	*	-
en_2793.txt	0	9	other	JJ	(NP*	-	-	-	-	*	-
en_2793.txt	0	10	occasions	NNS	*))	-	-	-	-	*	-
en_2793.txt	0	11	they	PRP	(NP*)	-	-	-	-	*	(5)
en_2793.txt	0	12	do	VBP	(VP*	-	-	-	-	*	-
en_2793.txt	0	13	not	RB	*	-	-	-	-	*	-
en_2793.txt	0	14	seem	VB	(VP*	-	-	-	-	*	-
en_2793.txt	0	15	justified	VBN	(VP*	-	-	-	-	*	-
en_2793.txt	0	16	–	SYM	(NP*)	-	-	-	-	*	-
en_2793.txt	0	17	especially	RB	(SBAR(ADVP*)	-	-	-	-	*	-
en_2793.txt	0	18	when	WRB	(WHADVP*)	-	-	-	-	*	-
en_2793.txt	0	19	considered	VBN	(S(VP*	-	-	-	-	*	-
en_2793.txt	0	20	from	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	21	the	DT	(NP(NP*	-	-	-	-	*	-
en_2793.txt	0	22	standpoint	NN	*)	-	-	-	-	*	-
en_2793.txt	0	23	of	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	24	enlightened	VBN	(NP*	-	-	-	-	*	-
en_2793.txt	0	25	self-interest	NN	*)))))))))))	-	-	-	-	*	-
en_2793.txt	0	26	.	.	*))	-	-	-	-	*	-

en_2793.txt	0	0	In	IN	(TOP(S(PP*	-	-	-	-	*	-
en_2793.txt	0	1	December	NNP	(NP*))	-	-	-	-	*	-
en_2793.txt	0	2	,	,	*	-	-	-	-	*	-
en_2793.txt	0	3	the	DT	(NP*	-	-	-	-	*	(9
en_2793.txt	0	4	pharmaceutical	JJ	*	-	-	-	-	*	-
en_2793.txt	0	5	giant	NN	*	-	-	-	-	*	-
en_2793.txt	0	6	Merck	NNP	*)	-	-	-	-	*	9)
en_2793.txt	0	7	spent	VBD	(VP*	-	-	-	-	*	-
en_2793.txt	0	8	$	$	(NP(QP*	-	-	-	-	*	-
en_2793.txt	0	9	8.4	CD	*	-	-	-	-	*	-
en_2793.txt	0	10	billion	CD	*))	-	-	-	-	*	-
en_2793.txt	0	11	to	TO	(S(VP*	-	-	-	-	*	-
en_2793.txt	0	12	acquire	VB	(VP*	-	-	-	-	*	-
en_2793.txt	0	13	Cubist	NNP	(NP(NP*	-	-	-	-	*	(10
en_2793.txt	0	14	Pharmaceuticals	NNP	*)	-	-	-	-	*	-
en_2793.txt	0	15	,	,	*	-	-	-	-	*	-
en_2793.txt	0	16	a	DT	(NP(NP*	-	-	-	-	*	-
en_2793.txt	0	17	Massachusetts-based	JJ	*	-	-	-	-	*	-
en_2793.txt	0	18	drug-maker	NN	*)	-	-	-	-	*	-
en_2793.txt	0	19	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_2793.txt	0	20	specializes	VBZ	(S(VP*	-	-	-	-	*	-
en_2793.txt	0	21	in	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	22	combating	VBG	(S(VP*	-	-	-	-	*	-
en_2793.txt	0	23	Methicillin-resistant	NNP	(NP(NP*	-	-	-	-	*	-
en_2793.txt	0	24	Staphylococcus	NNP	*	-	-	-	-	*	-
en_2793.txt	0	25	aureus	NNP	*)	-	-	-	-	*	-
en_2793.txt	0	26	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_2793.txt	0	27	MRSA	NNP	(NP*)	-	-	-	-	*	-
en_2793.txt	0	28	-RRB-	-RRB-	*)	-	-	-	-	*	-
en_2793.txt	0	29	,	,	*	-	-	-	-	*	-
en_2793.txt	0	30	a	DT	(NP(NP*	-	-	-	-	*	-
en_2793.txt	0	31	bacteria	NN	*)	-	-	-	-	*	-
en_2793.txt	0	32	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_2793.txt	0	33	has	VBZ	(S(VP*	-	-	-	-	*	-
en_2793.txt	0	34	become	VBN	(VP*	-	-	-	-	*	-
en_2793.txt	0	35	resistant	JJ	(ADJP*	-	-	-	-	*	-
en_2793.txt	0	36	to	TO	(PP*	-	-	-	-	*	-
en_2793.txt	0	37	many	JJ	(NP(NP*	-	-	-	-	*	-
en_2793.txt	0	38	types	NNS	*)	-	-	-	-	*	-
en_2793.txt	0	39	of	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	40	antibiotics	NNS	(NP*)))))))))))))))))))))))	-	-	-	-	*	10)
en_2793.txt	0	41	.	.	*))	-	-	-	-	*	-

en_2793.txt	0	0	In	IN	(TOP(S(PP*	-	-	-	-	*	-
en_2793.txt	0	1	early	JJ	(NP*	-	-	-	-	*	-
en_2793.txt	0	2	March	NNP	*))	-	-	-	-	*	-
en_2793.txt	0	3	–	SYM	(NP(NP*)	-	-	-	-	*	-
en_2793.txt	0	4	less	JJR	(PP(NP(QP*	-	-	-	-	*	-
en_2793.txt	0	5	than	IN	*	-	-	-	-	*	-
en_2793.txt	0	6	three	CD	*)	-	-	-	-	*	-
en_2793.txt	0	7	months	NNS	*)	-	-	-	-	*	-
en_2793.txt	0	8	after	IN	*	-	-	-	-	*	-
en_2793.txt	0	9	the	DT	(NP*	-	-	-	-	*	(9
en_2793.txt	0	10	acquisition	NN	*	-	-	-	-	*	-
en_2793.txt	0	11	–	NN	*	-	-	-	-	*	-
en_2793.txt	0	12	Merck	NN	*)))	-	-	-	-	*	9)
en_2793.txt	0	13	announced	VBD	(VP*	-	-	-	-	*	-
en_2793.txt	0	14	it	PRP	(SBAR(S(NP*)	-	-	-	-	*	(9)
en_2793.txt	0	15	would	MD	(VP*	-	-	-	-	*	-
en_2793.txt	0	16	close	VB	(VP*	-	-	-	-	*	-
en_2793.txt	0	17	down	RP	(PRT*)	-	-	-	-	*	-
en_2793.txt	0	18	Cubist	NNP	(NP(NP*	-	-	-	-	*	(10
en_2793.txt	0	19	'	POS	*)	-	-	-	-	*	10)
en_2793.txt	0	20	s	JJ	*	-	-	-	-	*	-
en_2793.txt	0	21	early-stage	JJ	*	-	-	-	-	*	-
en_2793.txt	0	22	research	NN	*	-	-	-	-	*	-
en_2793.txt	0	23	unit	NN	*)	-	-	-	-	*	-
en_2793.txt	0	24	,	,	*	-	-	-	-	*	-
en_2793.txt	0	25	laying	VBG	(S(VP(VP*	-	-	-	-	*	-
en_2793.txt	0	26	off	RP	(PRT*)	-	-	-	-	*	-
en_2793.txt	0	27	some	DT	(NP*	-	-	-	-	*	-
en_2793.txt	0	28	120	CD	*	-	-	-	-	*	-
en_2793.txt	0	29	staff	NN	*))	-	-	-	-	*	-
en_2793.txt	0	30	and	CC	*	-	-	-	-	*	-
en_2793.txt	0	31	perhaps	RB	(VP(ADVP*)	-	-	-	-	*	-
en_2793.txt	0	32	crippling	JJ	*	-	-	-	-	*	-
en_2793.txt	0	33	its	PRP$	(NP*	-	-	-	-	*	(9)
en_2793.txt	0	34	efforts	NNS	*	-	-	-	-	*	-
en_2793.txt	0	35	to	TO	(S(VP*	-	-	-	-	*	-
en_2793.txt	0	36	introduce	VB	(VP*	-	-	-	-	*	-
en_2793.txt	0	37	new	JJ	(NP*	-	-	-	-	*	-
en_2793.txt	0	38	drugs	NNS	*)	-	-	-	-	*	-
en_2793.txt	0	39	into	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	40	the	DT	(NP*	-	-	-	-	*	-
en_2793.txt	0	41	pipeline	NN	*))))))))))))))	-	-	-	-	*	-
en_2793.txt	0	42	.	.	*))	-	-	-	-	*	-

en_2793.txt	0	0	Three	CD	(TOP(S(ADVP(NP*	-	-	-	-	*	-
en_2793.txt	0	1	weeks	NNS	*)	-	-	-	-	*	-
en_2793.txt	0	2	later	RB	*)	-	-	-	-	*	-
en_2793.txt	0	3	,	,	*	-	-	-	-	*	-
en_2793.txt	0	4	Merck	NNP	(NP*)	-	-	-	-	*	(9)
en_2793.txt	0	5	announced	VBD	(VP*	-	-	-	-	*	-
en_2793.txt	0	6	that	IN	(SBAR*	-	-	-	-	*	-
en_2793.txt	0	7	it	PRP	(S(NP*)	-	-	-	-	*	(9)
en_2793.txt	0	8	would	MD	(VP*	-	-	-	-	*	-
en_2793.txt	0	9	spend	VB	(VP*	-	-	-	-	*	-
en_2793.txt	0	10	an	DT	(NP*	-	-	-	-	*	-
en_2793.txt	0	11	additional	JJ	*	-	-	-	-	*	-
en_2793.txt	0	12	$	$	(QP*	-	-	-	-	*	-
en_2793.txt	0	13	10	CD	*	-	-	-	-	*	-
en_2793.txt	0	14	billion	CD	*))	-	-	-	-	*	-
en_2793.txt	0	15	to	TO	(S(VP*	-	-	-	-	*	-
en_2793.txt	0	16	buy	VB	(VP*	-	-	-	-	*	-
en_2793.txt	0	17	back	RP	(PRT*)	-	-	-	-	*	-
en_2793.txt	0	18	some	DT	(NP(NP*)	-	-	-	-	*	-
en_2793.txt	0	19	of	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	20	its	PRP$	(NP*	-	-	-	-	*	(9)
en_2793.txt	0	21	shares	NNS	*)))))))))))	-	-	-	-	*	-
en_2793.txt	0	22	.	.	*))	-	-	-	-	*	-

en_2793.txt	0	0	It	PRP	(TOP(S(NP*)	-	-	-	-	*	(9)
en_2793.txt	0	1	is	VBZ	(VP*	-	-	-	-	*	-
en_2793.txt	0	2	difficult	JJ	(ADJP*)	-	-	-	-	*	-
en_2793.txt	0	3	for	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	4	an	DT	(NP*	-	-	-	-	*	-
en_2793.txt	0	5	outside	JJ	*	-	-	-	-	*	-
en_2793.txt	0	6	observer	NN	*))	-	-	-	-	*	-
en_2793.txt	0	7	not	RB	(S*	-	-	-	-	*	-
en_2793.txt	0	8	to	TO	(VP*	-	-	-	-	*	-
en_2793.txt	0	9	draw	VB	(VP*	-	-	-	-	*	-
en_2793.txt	0	10	a	DT	(NP(NP*	-	-	-	-	*	-
en_2793.txt	0	11	connection	NN	*)	-	-	-	-	*	-
en_2793.txt	0	12	between	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	13	the	DT	(NP*	-	-	-	-	*	-
en_2793.txt	0	14	two	CD	*	-	-	-	-	*	-
en_2793.txt	0	15	decisions	NNS	*)))))))	-	-	-	-	*	-
en_2793.txt	0	16	.	.	*))	-	-	-	-	*	-

en_2793.txt	0	0	Of	IN	(TOP(S(PP*	-	-	-	-	*	-
en_2793.txt	0	1	course	NN	(NP*))	-	-	-	-	*	-
en_2793.txt	0	2	,	,	*	-	-	-	-	*	-
en_2793.txt	0	3	dubious	JJ	(NP*	-	-	-	-	*	-
en_2793.txt	0	4	buybacks	NNS	*)	-	-	-	-	*	-
en_2793.txt	0	5	are	VBP	(VP*	-	-	-	-	*	-
en_2793.txt	0	6	not	RB	*	-	-	-	-	*	-
en_2793.txt	0	7	confined	VBN	(VP*	-	-	-	-	*	-
en_2793.txt	0	8	to	TO	(PP*	-	-	-	-	*	-
en_2793.txt	0	9	the	DT	(NP*	-	-	-	-	*	(5
en_2793.txt	0	10	pharmaceutical	JJ	*	-	-	-	-	*	-
en_2793.txt	0	11	industry	NN	*))))	-	-	-	-	*	5)
en_2793.txt	0	12	.	.	*))	-	-	-	-	*	-

en_2793.txt	0	0	Apple	NNP	(TOP(S(NP*)	-	-	-	-	*	(11)
en_2793.txt	0	1	is	VBZ	(VP*	-	-	-	-	*	-
en_2793.txt	0	2	another	DT	(NP*	-	-	-	-	*	-
en_2793.txt	0	3	good	JJ	*	-	-	-	-	*	-
en_2793.txt	0	4	example	NN	*))	-	-	-	-	*	-
en_2793.txt	0	5	.	.	*))	-	-	-	-	*	-

en_2793.txt	0	0	The	DT	(TOP(S(S(NP(NP*	-	-	-	-	*	(11
en_2793.txt	0	1	company	NN	*	-	-	-	-	*	-
en_2793.txt	0	2	'	POS	*)	-	-	-	-	*	11)
en_2793.txt	0	3	s	VBN	*	-	-	-	-	*	-
en_2793.txt	0	4	latest	JJS	*	-	-	-	-	*	-
en_2793.txt	0	5	quarterly	JJ	*	-	-	-	-	*	-
en_2793.txt	0	6	sales	NNS	*	-	-	-	-	*	-
en_2793.txt	0	7	results	NNS	*)	-	-	-	-	*	-
en_2793.txt	0	8	show	VBP	(VP*	-	-	-	-	*	-
en_2793.txt	0	9	how	WRB	(SBAR(WHADVP*)	-	-	-	-	*	-
en_2793.txt	0	10	the	DT	(S(NP*	-	-	-	-	*	(11
en_2793.txt	0	11	company	NN	*)	-	-	-	-	*	11)
en_2793.txt	0	12	has	VBZ	(VP*	-	-	-	-	*	-
en_2793.txt	0	13	become	VBN	(VP*	-	-	-	-	*	-
en_2793.txt	0	14	something	NN	(ADJP(ADJP*	-	-	-	-	*	-
en_2793.txt	0	15	more	JJR	*)	-	-	-	-	*	-
en_2793.txt	0	16	than	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	17	a	DT	(NP*	-	-	-	-	*	-
en_2793.txt	0	18	technology	NN	*	-	-	-	-	*	-
en_2793.txt	0	19	firm	NN	*)))))))))	-	-	-	-	*	-
en_2793.txt	0	20	;	:	*	-	-	-	-	*	-
en_2793.txt	0	21	it	PRP	(S(NP*)	-	-	-	-	*	(11)
en_2793.txt	0	22	is	VBZ	(VP*	-	-	-	-	*	-
en_2793.txt	0	23	now	RB	(ADVP*)	-	-	-	-	*	-
en_2793.txt	0	24	a	DT	(NP*	-	-	-	-	*	-
en_2793.txt	0	25	major	JJ	*	-	-	-	-	*	-
en_2793.txt	0	26	middle-class	JJ	*	-	-	-	-	*	-
en_2793.txt	0	27	Chinese	JJ	*	-	-	-	-	*	-
en_2793.txt	0	28	consumer	NN	*	-	-	-	-	*	-
en_2793.txt	0	29	brand	NN	*)))	-	-	-	-	*	-
en_2793.txt	0	30	.	.	*))	-	-	-	-	*	-

en_2793.txt	0	0	Within	IN	(TOP(S(PP*	-	-	-	-	*	-
en_2793.txt	0	1	a	DT	(NP*	-	-	-	-	*	-
en_2793.txt	0	2	year	NN	*))	-	-	-	-	*	-
en_2793.txt	0	3	,	,	*	-	-	-	-	*	-
en_2793.txt	0	4	China	NNP	(NP*)	-	-	-	-	*	(12)
en_2793.txt	0	5	will	MD	(VP*	-	-	-	-	*	-
en_2793.txt	0	6	likely	RB	(ADVP*)	-	-	-	-	*	-
en_2793.txt	0	7	be	VB	(VP*	-	-	-	-	*	-
en_2793.txt	0	8	a	DT	(NP(NP*	-	-	-	-	*	-
en_2793.txt	0	9	bigger	JJR	*	-	-	-	-	*	-
en_2793.txt	0	10	market	NN	*)	-	-	-	-	*	-
en_2793.txt	0	11	for	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	12	its	PRP$	(NP*	-	-	-	-	*	(12)
en_2793.txt	0	13	products	NNS	*))	-	-	-	-	*	-
en_2793.txt	0	14	than	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	15	the	DT	(NP*	-	-	-	-	*	-
en_2793.txt	0	16	United	NNP	*	-	-	-	-	*	-
en_2793.txt	0	17	States	NNPS	*)))))	-	-	-	-	*	-
en_2793.txt	0	18	.	.	*))	-	-	-	-	*	-

en_2793.txt	0	0	And	CC	(TOP(S*	-	-	-	-	*	-
en_2793.txt	0	1	yet	RB	(ADVP*)	-	-	-	-	*	-
en_2793.txt	0	2	,	,	*	-	-	-	-	*	-
en_2793.txt	0	3	even	RB	(NP(ADJP(ADJP*	-	-	-	-	*	-
en_2793.txt	0	4	more	RBR	*	-	-	-	-	*	-
en_2793.txt	0	5	striking	JJ	*)	-	-	-	-	*	-
en_2793.txt	0	6	than	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	7	this	DT	(NP(NP*	-	-	-	-	*	-
en_2793.txt	0	8	confirmation	NN	*)	-	-	-	-	*	-
en_2793.txt	0	9	of	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	10	the	DT	(NP(NP*	-	-	-	-	*	-
en_2793.txt	0	11	still-rising	JJ	*	-	-	-	-	*	-
en_2793.txt	0	12	importance	NN	*)	-	-	-	-	*	-
en_2793.txt	0	13	of	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	14	the	DT	(NP*	-	-	-	-	*	-
en_2793.txt	0	15	BRIC	NNP	*))	-	-	-	-	*	-
en_2793.txt	0	16	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_2793.txt	0	17	Brazil	NNP	(NP*)	-	-	-	-	*	-
en_2793.txt	0	18	,	,	*	-	-	-	-	*	-
en_2793.txt	0	19	Russia	NNP	(NP(NP*)	-	-	-	-	*	-
en_2793.txt	0	20	,	,	*	-	-	-	-	*	-
en_2793.txt	0	21	India	NNP	(NP*)	-	-	-	-	*	-
en_2793.txt	0	22	,	,	*	-	-	-	-	*	-
en_2793.txt	0	23	and	CC	*	-	-	-	-	*	-
en_2793.txt	0	24	China	NNP	(NP*))	-	-	-	-	*	(12)
en_2793.txt	0	25	-RRB-	-RRB-	*))))))	-	-	-	-	*	-
en_2793.txt	0	26	economies	NNS	*)	-	-	-	-	*	-
en_2793.txt	0	27	is	VBZ	(VP*	-	-	-	-	*	-
en_2793.txt	0	28	the	DT	(NP(NP*	-	-	-	-	*	-
en_2793.txt	0	29	sheer	JJ	*	-	-	-	-	*	-
en_2793.txt	0	30	size	NN	*)	-	-	-	-	*	-
en_2793.txt	0	31	of	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	32	Apple	NNP	(NP(NP*	-	-	-	-	*	(11
en_2793.txt	0	33	'	POS	*)	-	-	-	-	*	11)
en_2793.txt	0	34	s	JJ	*	-	-	-	-	*	-
en_2793.txt	0	35	ongoing	JJ	*	-	-	-	-	*	-
en_2793.txt	0	36	buyback	NN	*	-	-	-	-	*	-
en_2793.txt	0	37	program	NN	*))))	-	-	-	-	*	-
en_2793.txt	0	38	.	.	*))	-	-	-	-	*	-

en_2793.txt	0	0	In	IN	(TOP(S(PP*	-	-	-	-	*	-
en_2793.txt	0	1	April	NNP	(NP*))	-	-	-	-	*	-
en_2793.txt	0	2	,	,	*	-	-	-	-	*	-
en_2793.txt	0	3	the	DT	(NP*	-	-	-	-	*	(11
en_2793.txt	0	4	company	NN	*)	-	-	-	-	*	11)
en_2793.txt	0	5	announced	VBD	(VP*	-	-	-	-	*	-
en_2793.txt	0	6	it	PRP	(SBAR(S(NP*)	-	-	-	-	*	(11)
en_2793.txt	0	7	had	VBD	(VP*	-	-	-	-	*	-
en_2793.txt	0	8	authorized	VBN	(VP*	-	-	-	-	*	-
en_2793.txt	0	9	an	DT	(NP*	-	-	-	-	*	-
en_2793.txt	0	10	additional	JJ	*	-	-	-	-	*	-
en_2793.txt	0	11	$	$	(QP*	-	-	-	-	*	-
en_2793.txt	0	12	50	CD	*	-	-	-	-	*	-
en_2793.txt	0	13	billion	CD	*))	-	-	-	-	*	-
en_2793.txt	0	14	to	TO	(S(VP*	-	-	-	-	*	-
en_2793.txt	0	15	be	VB	(VP*	-	-	-	-	*	-
en_2793.txt	0	16	used	VBN	(VP*	-	-	-	-	*	-
en_2793.txt	0	17	for	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	18	repurchasing	VBG	(S(VP*	-	-	-	-	*	-
en_2793.txt	0	19	shares	NNS	(NP*))))))))))))	-	-	-	-	*	-
en_2793.txt	0	20	,	,	*	-	-	-	-	*	-
en_2793.txt	0	21	bringing	VBG	(S(VP*	-	-	-	-	*	-
en_2793.txt	0	22	the	DT	(NP*	-	-	-	-	*	-
en_2793.txt	0	23	total	NN	*)	-	-	-	-	*	-
en_2793.txt	0	24	to	TO	(PP*	-	-	-	-	*	-
en_2793.txt	0	25	$	$	(NP(QP*	-	-	-	-	*	-
en_2793.txt	0	26	140	CD	*	-	-	-	-	*	-
en_2793.txt	0	27	billion	CD	*))))))	-	-	-	-	*	-
en_2793.txt	0	28	.	.	*))	-	-	-	-	*	-

en_2793.txt	0	0	Coming	VBG	(TOP(S(S(VP*	-	-	-	-	*	-
en_2793.txt	0	1	at	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	2	a	DT	(NP(NP*	-	-	-	-	*	-
en_2793.txt	0	3	time	NN	*)	-	-	-	-	*	-
en_2793.txt	0	4	when	WRB	(SBAR(WHADVP*)	-	-	-	-	*	-
en_2793.txt	0	5	the	DT	(S(NP*	-	-	-	-	*	(5
en_2793.txt	0	6	technology	NN	*	-	-	-	-	*	-
en_2793.txt	0	7	industry	NN	*)	-	-	-	-	*	5)
en_2793.txt	0	8	is	VBZ	(VP*	-	-	-	-	*	-
en_2793.txt	0	9	under	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	10	increasing	VBG	(S(VP*	-	-	-	-	*	-
en_2793.txt	0	11	scrutiny	NN	(NP*)	-	-	-	-	*	-
en_2793.txt	0	12	in	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	13	the	DT	(NP*	-	-	-	-	*	-
en_2793.txt	0	14	developed	VBN	*	-	-	-	-	*	-
en_2793.txt	0	15	world	NN	*))	-	-	-	-	*	-
en_2793.txt	0	16	as	IN	(SBAR*	-	-	-	-	*	-
en_2793.txt	0	17	governments	NNS	(S(NP*)	-	-	-	-	*	-
en_2793.txt	0	18	struggle	NN	(VP*	-	-	-	-	*	-
en_2793.txt	0	19	with	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	20	budget	NN	(NP(NP*	-	-	-	-	*	-
en_2793.txt	0	21	shortfalls	NNS	*)	-	-	-	-	*	-
en_2793.txt	0	22	and	CC	*	-	-	-	-	*	-
en_2793.txt	0	23	rising	VBG	(NP*	-	-	-	-	*	-
en_2793.txt	0	24	debt	NN	*))))))))))))))))	-	-	-	-	*	-
en_2793.txt	0	25	,	,	*	-	-	-	-	*	-
en_2793.txt	0	26	this	DT	(NP*)	-	-	-	-	*	-
en_2793.txt	0	27	seems	VBZ	(VP*	-	-	-	-	*	-
en_2793.txt	0	28	to	TO	(PP*	-	-	-	-	*	-
en_2793.txt	0	29	me	PRP	(NP*))	-	-	-	-	*	(0)
en_2793.txt	0	30	to	TO	(S(VP*	-	-	-	-	*	-
en_2793.txt	0	31	be	VB	(VP*	-	-	-	-	*	-
en_2793.txt	0	32	a	DT	(NP*	-	-	-	-	*	-
en_2793.txt	0	33	questionable	JJ	*	-	-	-	-	*	-
en_2793.txt	0	34	decision	NN	*)))))	-	-	-	-	*	-
en_2793.txt	0	35	.	.	*))	-	-	-	-	*	-

en_2793.txt	0	0	Companies	NNS	(TOP(S(NP(NP*	-	-	-	-	*	(13
en_2793.txt	0	1	'	POS	*)	-	-	-	-	*	13)
en_2793.txt	0	2	ability	NN	*	-	-	-	-	*	-
en_2793.txt	0	3	to	TO	(S(VP*	-	-	-	-	*	-
en_2793.txt	0	4	minimize	VB	(VP*	-	-	-	-	*	-
en_2793.txt	0	5	their	PRP$	(NP*	-	-	-	-	*	(13)
en_2793.txt	0	6	global	JJ	*	-	-	-	-	*	-
en_2793.txt	0	7	tax	NN	*	-	-	-	-	*	-
en_2793.txt	0	8	burden	NN	*)))))	-	-	-	-	*	-
en_2793.txt	0	9	,	,	*	-	-	-	-	*	-
en_2793.txt	0	10	while	IN	(SBAR*	-	-	-	-	*	-
en_2793.txt	0	11	boosting	VBG	(S(VP*	-	-	-	-	*	-
en_2793.txt	0	12	their	PRP$	(NP(NP*	-	-	-	-	*	(13)
en_2793.txt	0	13	earnings	NNS	*)	-	-	-	-	*	-
en_2793.txt	0	14	per	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	15	share	NN	(NP*)))	-	-	-	-	*	-
en_2793.txt	0	16	through	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	17	buybacks	NNS	(NP*)))))	-	-	-	-	*	-
en_2793.txt	0	18	–	SYM	(NP(NP*)	-	-	-	-	*	-
en_2793.txt	0	19	in	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	20	some	DT	(NP*	-	-	-	-	*	-
en_2793.txt	0	21	cases	NNS	*))	-	-	-	-	*	-
en_2793.txt	0	22	financed	VBN	(VP*	-	-	-	-	*	-
en_2793.txt	0	23	with	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	24	debt	NN	(NP*	-	-	-	-	*	-
en_2793.txt	0	25	–	NN	*))))	-	-	-	-	*	-
en_2793.txt	0	26	does	VBZ	(VP*	-	-	-	-	*	-
en_2793.txt	0	27	not	RB	*	-	-	-	-	*	-
en_2793.txt	0	28	strike	VB	(VP*	-	-	-	-	*	-
en_2793.txt	0	29	me	PRP	(NP*)	-	-	-	-	*	(0)
en_2793.txt	0	30	as	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	31	a	DT	(NP*	-	-	-	-	*	-
en_2793.txt	0	32	stable	JJ	*	-	-	-	-	*	-
en_2793.txt	0	33	trend	NN	*))))	-	-	-	-	*	-
en_2793.txt	0	34	.	.	*))	-	-	-	-	*	-

en_2793.txt	0	0	When	WRB	(TOP(S(SBAR(WHADVP*)	-	-	-	-	*	-
en_2793.txt	0	1	companies	NNS	(S(NP*)	-	-	-	-	*	(14)
en_2793.txt	0	2	are	VBP	(VP*	-	-	-	-	*	-
en_2793.txt	0	3	genuinely	RB	(ADVP*)	-	-	-	-	*	-
en_2793.txt	0	4	unable	JJ	(ADJP*	-	-	-	-	*	-
en_2793.txt	0	5	to	TO	(S(VP*	-	-	-	-	*	-
en_2793.txt	0	6	identify	VB	(VP*	-	-	-	-	*	-
en_2793.txt	0	7	areas	NNS	(NP(NP*)	-	-	-	-	*	-
en_2793.txt	0	8	of	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	9	research	NN	(NP*	-	-	-	-	*	-
en_2793.txt	0	10	and	CC	*	-	-	-	-	*	-
en_2793.txt	0	11	investment	NN	*))	-	-	-	-	*	-
en_2793.txt	0	12	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_2793.txt	0	13	would	MD	(S(VP*	-	-	-	-	*	-
en_2793.txt	0	14	help	VB	(VP*	-	-	-	-	*	-
en_2793.txt	0	15	their	PRP$	(NP*	-	-	-	-	*	(14)
en_2793.txt	0	16	business	NN	*)	-	-	-	-	*	-
en_2793.txt	0	17	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_2793.txt	0	18	and	CC	*	-	-	-	-	*	-
en_2793.txt	0	19	employees	NNS	(NP*	-	-	-	-	*	-
en_2793.txt	0	20	and	CC	*	-	-	-	-	*	-
en_2793.txt	0	21	clients	NNS	*)	-	-	-	-	*	-
en_2793.txt	0	22	-RRB-	-RRB-	*)))))))))))))	-	-	-	-	*	-
en_2793.txt	0	23	,	,	*	-	-	-	-	*	-
en_2793.txt	0	24	they	PRP	(NP*)	-	-	-	-	*	(14)
en_2793.txt	0	25	are	VBP	(VP*	-	-	-	-	*	-
en_2793.txt	0	26	better	JJR	(ADJP(ADJP*	-	-	-	-	*	-
en_2793.txt	0	27	off	RP	*	-	-	-	-	*	-
en_2793.txt	0	28	returning	VBG	(S(VP*	-	-	-	-	*	-
en_2793.txt	0	29	the	DT	(NP*	-	-	-	-	*	-
en_2793.txt	0	30	savings	NNS	*)	-	-	-	-	*	-
en_2793.txt	0	31	to	TO	(PP*	-	-	-	-	*	-
en_2793.txt	0	32	shareholders	NNS	(NP*))	-	-	-	-	*	-
en_2793.txt	0	33	in	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	34	the	DT	(NP(NP*	-	-	-	-	*	-
en_2793.txt	0	35	form	NN	*)	-	-	-	-	*	-
en_2793.txt	0	36	of	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	37	higher	JJR	(NP*	-	-	-	-	*	-
en_2793.txt	0	38	dividends	NNS	*)))))))	-	-	-	-	*	-
en_2793.txt	0	39	than	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	40	authorizing	VBG	(NP*	-	-	-	-	*	-
en_2793.txt	0	41	buybacks	NNS	*))))	-	-	-	-	*	-
en_2793.txt	0	42	.	.	*))	-	-	-	-	*	-

en_2793.txt	0	0	Or	CC	(TOP(FRAG*	-	-	-	-	*	-
en_2793.txt	0	1	,	,	*	-	-	-	-	*	-
en_2793.txt	0	2	better	RBR	(FRAG(ADVP*	-	-	-	-	*	-
en_2793.txt	0	3	yet	RB	*))	-	-	-	-	*	-
en_2793.txt	0	4	,	,	*	-	-	-	-	*	-
en_2793.txt	0	5	in	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	6	a	DT	(NP(NP*	-	-	-	-	*	-
en_2793.txt	0	7	world	NN	*)	-	-	-	-	*	-
en_2793.txt	0	8	confronted	VBN	(VP*	-	-	-	-	*	-
en_2793.txt	0	9	with	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	10	a	DT	(NP(NP*	-	-	-	-	*	-
en_2793.txt	0	11	host	NN	*)	-	-	-	-	*	-
en_2793.txt	0	12	of	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	13	problems	NNS	(NP*)))))))	-	-	-	-	*	-
en_2793.txt	0	14	–	SYM	(X*)	-	-	-	-	*	-
en_2793.txt	0	15	from	IN	(PP(PP*	-	-	-	-	*	-
en_2793.txt	0	16	climate	NN	(NP*	-	-	-	-	*	-
en_2793.txt	0	17	change	NN	*))	-	-	-	-	*	-
en_2793.txt	0	18	to	TO	(PP*	-	-	-	-	*	-
en_2793.txt	0	19	antimicrobial	JJ	(NP*	-	-	-	-	*	-
en_2793.txt	0	20	resistance	NN	*)))	-	-	-	-	*	-
en_2793.txt	0	21	–	SYM	(X*)	-	-	-	-	*	-
en_2793.txt	0	22	industry	NN	(S(NP*	-	-	-	-	*	(15
en_2793.txt	0	23	leaders	NNS	*)	-	-	-	-	*	15)
en_2793.txt	0	24	should	MD	(VP*	-	-	-	-	*	-
en_2793.txt	0	25	begin	VB	(VP*	-	-	-	-	*	-
en_2793.txt	0	26	asking	VBG	(S(VP*	-	-	-	-	*	-
en_2793.txt	0	27	themselves	PRP	(NP*)	-	-	-	-	*	(15)
en_2793.txt	0	28	how	WRB	(SBAR(WHADVP*)	-	-	-	-	*	-
en_2793.txt	0	29	they	PRP	(S(NP*)	-	-	-	-	*	(15)
en_2793.txt	0	30	can	MD	(VP*	-	-	-	-	*	-
en_2793.txt	0	31	contribute	VB	(VP*	-	-	-	-	*	-
en_2793.txt	0	32	to	TO	(PP*	-	-	-	-	*	-
en_2793.txt	0	33	averting	VBG	(S(VP*	-	-	-	-	*	-
en_2793.txt	0	34	the	DT	(NP(NP*	-	-	-	-	*	-
en_2793.txt	0	35	crises	NNS	*)	-	-	-	-	*	-
en_2793.txt	0	36	of	IN	(PP*	-	-	-	-	*	-
en_2793.txt	0	37	the	DT	(NP*	-	-	-	-	*	-
en_2793.txt	0	38	future	NN	*)))))))))))))))	-	-	-	-	*	-
en_2793.txt	0	39	.	.	*))	-	-	-	-	*	-

#end document
